Has Neuroscience Society Growth Been Too Fast For Its Own Good?

Forty-five years ago David Hubel thought he would become a physicist. That is, until he went to his first international scientific meeting. “I was scared off by the number of people,” recalls Hubel so he switched to a science still in its infancy and far more intimate—a science called neurophysiology, The move proved to be very useful for science—in 1981 Hubel received the Nobel Prize in medicine for his contributions to understanding the organization and functioning of

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Forty-five years ago David Hubel thought he would become a physicist. That is, until he went to his first international scientific meeting. “I was scared off by the number of people,” recalls Hubel so he switched to a science still in its infancy and far more intimate—a science called neurophysiology, The move proved to be very useful for science—in 1981 Hubel received the Nobel Prize in medicine for his contributions to understanding the organization and functioning of the brain.

But today Hubel a professor at Harvard, must worry that his field is going through the same explosive growth that drove him away from physics. As president of the 14,000-member Society for Neuroscience, which is holding its 19th annual meeting this week in Phoenix, Hubel is grappling with the possibility that this growth will discourage the next generation of world-class scientists anO unoermine me society s very reason for being. “I ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Elizabeth Pennisi

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide